While many antitauon therapies have reached clinical trials, results have been mixed:
The concept of "tauons" arises from the observation that misfolded tau protein isoforms can propagate through the brain in a characteristic pattern, similar to prions, driving the progression of conditions like Alzheimer's disease. Antitauon therapies aim to intervene in this process through several key mechanisms:
Stopping tau proteins from sticking together to form toxic seeds.
Promoting the removal of pathological tau via microglia or through intracellular degradation pathways like the proteasome. Key Therapeutic Strategies
While many antitauon therapies have reached clinical trials, results have been mixed:
The concept of "tauons" arises from the observation that misfolded tau protein isoforms can propagate through the brain in a characteristic pattern, similar to prions, driving the progression of conditions like Alzheimer's disease. Antitauon therapies aim to intervene in this process through several key mechanisms:
Stopping tau proteins from sticking together to form toxic seeds.
Promoting the removal of pathological tau via microglia or through intracellular degradation pathways like the proteasome. Key Therapeutic Strategies
На сайте осуществляется обработка пользовательских
данных с использованием cookie в соответствии с политикой конфиденциальности.
Вы можете запретить сохранение cookie в настройках своего браузера.